Seeking Alternative Catalyst Solutions
Transition metal-containing catalysts are widely used in organic synthesis, but many are based on expensive, rare metals. Researchers are seeking more sustainable alternatives.

Advertisement: NATOLI Tablet Press Manufacturing and Refurbishing Need a new R&D, medium to high-production tablet press?  Contact “The Global Leader” in the tablet compression industry. NATOLI Engineering also refurbishes tablet press with results that often exceed the efficiency and functionality of the original. Learn more about NATOLI’s renowned experience in building and refurbishing tablet presses.  All NATOLI Tablet Presses are Made in the U.S.A..

Gowning Practices Provide Clues to cGMP Compliance
In legacy facilities and as buildings age, ensuring cGMP compliance can become complex. A review of a facility's gowning operations can bring insight into the current state of cGMP compliance. The author presents characteristics to look for and questions to ask.

Outsourcing No Longer Just for Cost-Cutting
With budgets growing, clients see CMOs' costs as less crucial.

Advertisement: Nisso low viscosity HPC for dry binding Special low viscosity, super fine powder grade Nisso HPC-SSL-SFP is a new dry binder for direct compression, ODT, roller compaction, extra-granule addition applications.  Excellent tablet hardness and friability properties can be achieved in dry binding applications using 3% or less of binder and with minimal-to-no impact on disintegration times and dissolution profiles. Read more.

Covance MarketPlace Connects Biotech with Potential Partners
Covance MarketPlace is designed to enable partnerships between the company’s emerging biotechnology and established pharmaceutical clients.

Aesica Pharmaceuticals S.r.I. Implements Serialization System
Aesica Pharmaceuticals S.r.I. collaborates with QAD to meet China’s Food and Drug Administration’s shortened serialization deadline.

Advertisement: Analytical Challenges and Case Studies in Method Development for Fixed-Dose Combinations Thursday, July 17, 2014 at 11:00 AM EDT To Register Free: www.pharmtech.com/method_development

Study Demonstrates Performance of SMARTag Platform
New toxicology study demonstrates decreased mortality and better tolerability of ADC generated with Smartag platform versus conventional technology.

Recipharm and CTC Enter Collaboration
Recipharm and CTC will offer packages for Phase I studies.

NIH launches 3D Print Exchange for Researchers
NIH launched 3D Print Exchange, a public website promoting health and science applications of 3D printing.